| Name | Value |
|---|---|
| Revenues | 132.5M |
| Cost of Revenue | 45.1M |
| Gross Profit | 87.4M |
| Operating Expense | 115.5M |
| Operating I/L | -28.1M |
| Other Income/Expense | 0.7M |
| Interest Income | 1.7M |
| Pretax | -38.4M |
| Income Tax Expense | 0.3M |
| Net Income/Loss | -38.7M |
iRhythm Technologies, Inc. is a digital healthcare company specializing in ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. Its flagship Zio service offers a wire-free, patch-based, and wearable biosensor combined with a cloud-based data analytic platform, enabling physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors are single-use, wire-free, wearable patch-based biosensors that record patient's heartbeats and ECG data. iRhythm generates revenue by selling its monitoring products and services to healthcare providers and patients.